nach oben

Inflammopharmacology

Erschienen in:

20.12.2021 | COVID-19 | Correction Zur Zeit gratis

Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case–control study

verfasst von: Mahsa Mohajeri, Ehsan Horriatkhah, Reza Mohajery

Erschienen in: Inflammopharmacology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

There was a writing typo in Table 3. In fact, 38 of the 123 patients admitted to the ICU have died (30.89%). This mortality rate was from 123 patients admitted to ICU. …

Titel: Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case–control study
verfasst von: Mahsa Mohajeri
Ehsan Horriatkhah
Reza Mohajery
Publikationsdatum: 20.12.2021
Verlag: Springer International Publishing
Schlagwort: COVID-19
Erschienen in: Inflammopharmacology / Ausgabe 1/2022
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-021-00898-5

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?

The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis

Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection

Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-α production

Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model

Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study